The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMkango Res Regulatory News (MKA)

Share Price Information for Mkango Res (MKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.25
Bid: 7.00
Ask: 7.50
Change: 0.15 (2.11%)
Spread: 0.50 (7.143%)
Open: 7.10
High: 7.50
Low: 6.56
Prev. Close: 7.10
MKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COTEC FUNDING INSTALMENT RECEIVED

6 Feb 2023 14:30

RNS Number : 0592P
Mkango Resources Limited
06 February 2023
 

 

 

 

 

 

MKANGO RESOURCES LTD.

550 Burrard Street

Suite 2900

Vancouver

BC V6C 0A3

Canada

 

COTEC FUNDING INSTALMENT RECEIVED

 

London, U.K. and Vancouver, CANADA - February 6, 2022 - Mkango Resources Ltd. (AIM/TSX-V: MKA) (the "Company" or "Mkango") is pleased to announce that, further to the announcement on 1st February 2022, Mkango has received the £452,500 from CoTec (C$729,839), being the final instalment under the £2,000,000 convertible loan agreement providing for a two-year, secured convertible loan from CoTec to Mkango (the "Convertible Loan") with 5% interest, convertible into Mkango shares at 27p each or, under certain condition, into shares of Mkango's subsidiary, Maginito Limited.

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

Cautionary Note Regarding Forward-Looking Statements

This news release may contain forward-looking statements (within the meaning of that term under applicable securities laws) with respect to Mkango, and CoTec. Generally, forward looking statements can be identified by the use of words such as "plans", "expects" or "is expected to", "scheduled", "estimates" "intends", "anticipates", "believes", or variations of such words and phrases, or statements that certain actions, events or results "can", "may", "could", "would", "should", "might" or "will", occur or be achieved, or the negative connotations thereof. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements.

 

For further information on Mkango, please contact:

Mkango Resources Limited

 

William Dawes Alexander Lemon

Chief Executive Officer President

will@mkango.ca alex@mkango.ca

Canada: +1 403 444 5979

www.mkango.ca

@MkangoResources

 

BlytheRay

Financial Public Relations

Tim Blythe

UK: +44 207 138 3204

 

SP Angel Corporate Finance LLP

Nominated Adviser and Joint Broker

Jeff Keating, Caroline Rowe

UK: +44 20 3470 0470

 

Alternative Resource Capital

Joint Broker

Alex Wood, Keith Dowsing

UK: +44 20 7186 9004/5

 

The TSX Venture Exchange has neither approved nor disapproved the contents of this press release. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any equity or other securities of the Company in the United States. The securities of the Company will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") and may not be offered or sold within the United States to, or for the account or benefit of, U.S. persons except in certain transactions exempt from the registration requirements of the U.S. Securities Act.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSAFLMEDSESE
Date   Source Headline
5th Jul 20227:00 amRNSMKANGO ANNOUNCES RESULTS OF DFS FOR SONGWE HILL
30th Jun 20222:30 pmRNSMKANGO APPOINTS ROB SEWELL AS CFO
21st Jun 20227:00 amRNSMKANGO AND COTEC PROVIDE TRANSACTION UPDATE
31st May 20227:00 amRNSMKANGO ANNOUNCES Q1 2022 RESULTS
30th May 20227:00 amRNSMKANGO AND COTEC TO COLLABORATE
10th May 202210:18 amRNSHolding(s) in Company
28th Apr 20227:00 amRNSMKANGO ANNOUNCES Q4 2021 AND YEAR END RESULTS
7th Apr 20227:00 amRNSMKANGO COMPLETES INITIAL SAMPLING AT NKALONJE
14th Mar 20227:00 amRNSMKANGO AND HYPROMAG TO COLLABORATE IN NEW PROJECT
11th Mar 20227:00 amRNSERMA PRESS RELEASE
10th Mar 20227:00 amRNSMKANGO ISSUES SHARES TO BACCHUS CAPITAL
7th Mar 20227:00 amRNSMKANGO ANNOUNCES FINDINGS FROM FINAL PILOTING
21st Feb 202210:51 amRNSHolding(s) in Company
18th Feb 20227:00 amRNSHolding(s) in Company
14th Dec 20217:00 amRNSMKANGO COMMENCES FINAL HYDROMETALLURGY PILOTING
7th Dec 20217:00 amRNSHolding(s) in Company
30th Nov 20217:00 amRNSMKANGO ANNOUNCES Q3 2021 RESULTS
15th Nov 20217:00 amRNSMKANGO ANNOUNCES HYPROMAG EXPANSION INTO GERMANY
11th Nov 20217:00 amRNSMKANGO RENEWS THAMBANI URANIUM LICENCES IN MALAWI
4th Nov 20214:41 pmRNSSecond Price Monitoring Extn
4th Nov 20214:36 pmRNSPrice Monitoring Extension
3rd Nov 20217:00 amRNSMKANGO INCREASES INTEREST IN RECYCLER HYPROMAG
1st Nov 20217:00 amRNSMKANGO ANNOUNCES CLOSING OF TALAXIS TRANSACTION
6th Oct 20213:00 pmRNSMKANGO ANNOUNCES RESULTS OF AGM
30th Sep 20217:00 amRNSMKANGO ANNOUNCES COMPLETION OF PROJECT BY HYPROMAG
23rd Sep 20217:00 amRNSMKANGO COMMENCES GEOTECHNICAL DRILLING AT SONGWE
8th Sep 20217:00 amRNSHolding(s) in Company
31st Aug 20217:00 amRNSMKANGO RELEASES FINANCIAL STATEMENTS
16th Aug 20217:00 amRNSMKANGO PROVIDES UPDATE ON PLACING
5th Aug 202111:05 amRNSSecond Price Monitoring Extn
5th Aug 202111:00 amRNSPrice Monitoring Extension
5th Aug 20217:00 amRNSMKANGO TO ACQUIRE 100% OF SONGWE AND MAGINITO
7th Jun 20212:30 pmRNSMKANGO INVESTOR CONFERENCE CALL
7th Jun 20217:00 amRNSMKANGO TO CREATE RARE EARTHS HUB IN POLAND
25th May 20217:00 amRNSMKANGO ANNOUNCES Q1 2021 RESULTS
19th May 20219:00 amRNSPrice Monitoring Extension
18th May 20214:40 pmRNSSecond Price Monitoring Extn
18th May 20214:36 pmRNSPrice Monitoring Extension
18th May 20212:06 pmRNSSecond Price Monitoring Extn
18th May 20212:00 pmRNSPrice Monitoring Extension
5th May 20217:00 amRNSMKANGO INVESTOR CONFERENCE CALL
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:00 amRNSMKANGO ANNOUNCES RESULTS OF FLOTATION PILOTING
30th Apr 20216:15 pmRNSMKANGO ANNOUNCES 2020 FULL YEAR RESULTS
20th Apr 20217:00 amRNSMKANGO APPOINTS JGI TO ADVISE ON U.S STRATEGY
2nd Mar 20217:00 amRNSMKANGO COMPLETES FLOTATION PILOT PLANT PROGRAMME
24th Feb 20217:00 amRNSMKANGO COMMENCES PILOT PLANT PROCESSING
8th Feb 20217:00 amRNSMKANGO ISSUES SHARES TO BACCHUS CAPITAL
8th Jan 20212:01 pmRNSPrice Monitoring Extension
7th Jan 20217:00 amRNSMKANGO RECEIVES APPROVAL FOR WARRANT EXERCISE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.